Cargando…

Antibacterial Activity of Bifidobacterium breve Against Clostridioides difficile

Bifidobacterium breve (YH68) is widely used in the fields of food fermentation and biomedicine. In this study, we explored the antibacterial activity of the cell free culture supernatant (CFCS) of YH68 against Clostridioides difficile ATCC 9689 (CD) by measuring multiple indexes, including the growt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jingpeng, Yang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693512/ https://www.ncbi.nlm.nih.gov/pubmed/31440478 http://dx.doi.org/10.3389/fcimb.2019.00288

Ejemplares similares

Transcriptome Analysis of the Clostridioides difficile Response to Different Doses of Bifidobacterium breve
por: Yang, Jingpeng, et al.
Publicado: (2020)

Effect of Bifidobacterium breve in Combination With Different Antibiotics on Clostridium difficile
por: Yang, Jingpeng, et al.
Publicado: (2018)

Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model
por: Yang, Jingpeng, et al.
Publicado: (2022)

Systematic review of guidelines for the diagnosis and treatment of Clostridioides difficile infection
por: Gu, Ting, et al.
Publicado: (2022)

2’-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection
por: Wiese, Maria, et al.
Publicado: (2022)

Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile
por: Rahmoun, Layan Abu, et al.
Publicado: (2021)

An Atypical Case of Monomicrobial Clostridioides difficile Septicemia With No Gastrointestinal Manifestations
por: Wang, Liqian, et al.
Publicado: (2022)

Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non–C. difficile diarrhea, and C. difficile–colonized patients
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

Gut Microbiota Diversity of Preterm Neonates Is Associated With Clostridioides Difficile Colonization
por: Couturier, Jeanne, et al.
Publicado: (2022)

The impact of dietary fibers on Clostridioides difficile infection in a mouse model
por: Wu, Zhengjie, et al.
Publicado: (2022)

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
por: Yu, Si, et al.
Publicado: (2023)

Microbiome profile and calprotectin levels as markers of risk of recurrent Clostridioides difficile infection
por: Vázquez-Cuesta, Silvia, et al.
Publicado: (2023)

Transition From PCR-Ribotyping to Whole Genome Sequencing Based Typing of Clostridioides difficile
por: Seth-Smith, Helena M. B., et al.
Publicado: (2021)

High Prevalence of Multidrug-Resistant Clostridioides difficile Following Extensive Use of Antimicrobials in Hospitalized Patients in Kenya
por: Mutai, Winnie C., et al.
Publicado: (2021)

Application of a core genome sequence typing (cgMLST) pipeline for surveillance of Clostridioides difficile in China
por: Wang, Yuan Yuan, et al.
Publicado: (2023)

Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection
por: Kulecka, Maria, et al.
Publicado: (2023)

High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With Clostridioides Difficile Infection
por: Lee, Sang Hoon, et al.
Publicado: (2022)

Unveiling the inhibition mechanism of Clostridioides difficile by Bifidobacterium longum via multiomics approach
por: Jo, Sung-Hyun, et al.
Publicado: (2023)

S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During Clostridioides difficile Infection by Modulating Inflammatory Response
por: Costa, Deiziane V. S., et al.
Publicado: (2021)

Production of p-cresol by Decarboxylation of p-HPA by All Five Lineages of Clostridioides difficile Provides a Growth Advantage
por: Harrison, Mark A., et al.
Publicado: (2021)

Trehalose-Induced Remodelling of the Human Microbiota Affects Clostridioides difficile Infection Outcome in an In Vitro Colonic Model: A Pilot Study
por: Buckley, Anthony M., et al.
Publicado: (2021)

Comparative biofilm-forming ability between Clostridioides difficile strains isolated in Latin America and the epidemic NAP1/027 strain
por: Morais, Maria Luana Gaudencio dos Santos, et al.
Publicado: (2022)

Low Density Lipoprotein Receptor-Related Protein-1 (LRP1) Is Involved in the Uptake of Clostridioides difficile Toxin A and Serves as an Internalizing Receptor
por: Schöttelndreier, Dennis, et al.
Publicado: (2020)

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China
por: Chen, Yunbo, et al.
Publicado: (2022)

Antibacterial activity mechanism of coptisine against Pasteurella multocida
por: Zhang, Rui, et al.
Publicado: (2023)

Leptin Receptor q223r Polymorphism Influences Clostridioides difficile Infection-Induced Neutrophil CXCR2 Expression in an Interleukin-1β Dependent Manner
por: Horrigan, Olivia, et al.
Publicado: (2021)

Efficacy of lyophilised bacteria-rich faecal sediment and supernatant with reduced bacterial count for treating patients with Clostridioides difficile Infection – A novel method for capsule faecal microbiota transfer
por: Varga, Adorján, et al.
Publicado: (2023)

Risk factors for colonization with multidrug-resistant Gram-negative bacteria and Clostridioides difficile in Long Term Care Facilities (LTCFs) residents: the evidence from 27 facilities in a high endemic setting
por: Azzini, Anna Maria, et al.
Publicado: (2023)

Antibacterial activity of the novel oxazolidinone contezolid (MRX-I) against Mycobacterium abscessus
por: Gao, Shan., et al.
Publicado: (2023)

Antibacterial activity of the novel compound Sudapyridine (WX-081) against Mycobacterium abscessus
por: Nie, Wenjuan, et al.
Publicado: (2023)

A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
por: Khan, Fazal Mehmood, et al.
Publicado: (2021)

Effect and Mechanism of Bifidobacterium animalis B94 in the Prevention and Treatment of Liver Injury in Rats
por: Zhang, Tianfang, et al.
Publicado: (2022)

Gut Microbiota Composition Associated With Clostridium difficile-Positive Diarrhea and C. difficile Type in ICU Patients
por: Duan, Juping, et al.
Publicado: (2020)

Comparative Study of Bacillus amyloliquefaciens X030 on the Intestinal Flora and Antibacterial Activity Against Aeromonas of Grass Carp
por: Zhou, Pengji, et al.
Publicado: (2022)

Synthesis, characterization, and antibacterial activities of a heteroscorpionate derivative platinum complex against methicillin-resistant Staphylococcus aureus
por: Nam-Cha, Syong H., et al.
Publicado: (2023)

Maternal gestational Bifidobacterium bifidum TMC3115 treatment shapes construction of offspring gut microbiota and development of immune system and induces immune tolerance to food allergen
por: Cheng, Ruyue, et al.
Publicado: (2022)

Fighting the Antibiotic Crisis: Flavonoids as Promising Antibacterial Drugs Against Helicobacter pylori Infection
por: González, Andrés, et al.
Publicado: (2021)

Editorial: Clostridium difficile infection in the Asia-Pacific region
por: Jin, Dazhi, et al.
Publicado: (2022)

Bifidobacterium Treated by Electrostatic Spray Drying Relieved Constipation by Changing the Relative Abundance of Bacteria Associated With Gastrointestinal Regulatory Peptides
por: Jiang, Tian, et al.
Publicado: (2022)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_66p6cphnp3n12sqbdtpm85mq03